Clinical Trials Directory

Trials / Conditions / Leukemia, T-Cell

Leukemia, T-Cell

11 registered clinical trials studyying Leukemia, T-Cell — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingSafety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymp
NCT07471789
Gyala TherapeuticsPhase 1 / Phase 2
Not Yet RecruitingChimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
NCT06345027
Baylor College of MedicinePhase 1
CompletedCell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia
NCT04938115
Hebei Senlang Biotechnology Inc., Ltd.N/A
UnknownCAR-T Cells in the Treatment of Malignant Hematological Tumors
NCT05619861
Hebei Senlang Biotechnology Inc., Ltd.N/A
UnknownPrecision Exercise in Children With Malignant Hemopathies
NCT04090268
University of Milano BicoccaN/A
TerminatedRe-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma
NCT02518750
St. Jude Children's Research HospitalPhase 2
UnknownPrecision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL
NCT03553238
Nanfang Hospital, Southern Medical UniversityPhase 2 / Phase 3
UnknownPrecision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
NCT03564704
Nanfang Hospital, Southern Medical UniversityPhase 2 / Phase 3
CompletedRepeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia
NCT00095381
BioCryst PharmaceuticalsPhase 2
CompletedTreatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
NCT00001533
National Heart, Lung, and Blood Institute (NHLBI)Phase 1
CompletedTreatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 R
NCT00001249
National Cancer Institute (NCI)Phase 1